Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Corpus Uteri”

191 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 191 results

Not applicableStudy completedNCT06585553
What this trial is testing

Atrophic Gastritis and OLGIM Stage

Who this might be right for
Intestinal Metaplasia
Shandong University 2,121
Not applicableStudy completedNCT01208467
What this trial is testing

Prognostic Biomarkers in Patients With Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaRecurrent Uterine Corpus CarcinomaStage I Uterine Corpus Cancer+3 more
Gynecologic Oncology Group 2,824
Testing effectiveness (Phase 2)Study completedNCT01935934
What this trial is testing

Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Endometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Cell Adenocarcinoma+7 more
National Cancer Institute (NCI) 102
Not applicableStudy completedNCT00005016
What this trial is testing

Study of the Experiences and Needs of Parents Continuing a Pregnancy Following a Prenatal Diagnosis of Holopresencephaly

Who this might be right for
Holoprosencephaly
National Human Genome Research Institute (NHGRI) 30
Not applicableStudy completedNCT00341133
What this trial is testing

Genetic Analysis of Left-Right Axis Formations

Who this might be right for
Congenital Heart Disease
National Human Genome Research Institute (NHGRI) 900
Testing effectiveness (Phase 2)Active Not RecruitingNCT00788671
What this trial is testing

Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer

Who this might be right for
Atypical Endometrial HyperplasiaStage I Uterine Corpus Cancer AJCC v7Stage IA Uterine Corpus Cancer AJCC v7+2 more
M.D. Anderson Cancer Center 69
Not applicableStudy completedNCT04501913
What this trial is testing

Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes

Who this might be right for
Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage 0 Gastric Cancer AJCC v8+169 more
City of Hope Medical Center 22
Post-approval studies (Phase 4)Looking for participantsNCT06896617
What this trial is testing

Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET)

Who this might be right for
InfertilitiesEmbryo Transfer
Fundacion Clinic per a la Recerca Biomédica 334
Very early researchActive Not RecruitingNCT04494113
What this trial is testing

Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy

Who this might be right for
Endometrial Serous Adenocarcinoma
National Cancer Institute (NCI) 12
Not applicableUnknownNCT04787159
What this trial is testing

Endometrial Cancer International Database

Who this might be right for
Endometrial Cancer
Assiut University 1,000
Not applicableStudy completedNCT02167568
What this trial is testing

Corpus Callosum Agenesis and Intellectual Disability

Who this might be right for
Intellectual DeficiencyCerebral Abnormality
Assistance Publique - Hôpitaux de Paris 360
Early research (Phase 1)Not Yet RecruitingNCT03463239
What this trial is testing

Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora

Who this might be right for
Urologic DiseasesMale Urogenital DiseasesPenile Diseases+3 more
Wake Forest University Health Sciences 10
Not applicableWithdrawnNCT00250770
What this trial is testing

Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis

Who this might be right for
Uterine NeoplasmsEndometrial Neoplasms
University of New Mexico
Testing effectiveness (Phase 2)Study completedNCT02684227
What this trial is testing

Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer

Who this might be right for
Recurrent Endometrial Endometrioid AdenocarcinomaRecurrent Uterine Corpus CarcinomaStage III Uterine Corpus Cancer AJCC v7+6 more
M.D. Anderson Cancer Center 50
Not applicableUnknownNCT00956670
What this trial is testing

Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer

Who this might be right for
LymphedemaStage IA Cervical CancerStage IA Uterine Corpus Cancer+11 more
Gynecologic Oncology Group 1,055
Early research (Phase 1)Looking for participantsNCT04704661
What this trial is testing

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Who this might be right for
Advanced Breast CarcinomaAdvanced Colon CarcinomaAdvanced Colorectal Carcinoma+37 more
National Cancer Institute (NCI) 51
Not applicableLooking for participantsNCT05140265
What this trial is testing

De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information

Who this might be right for
EpilepsyStatus EpilepticusSeizures
University of New Mexico 20,000
Not applicableLooking for participantsNCT03223922
What this trial is testing

Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

Who this might be right for
Brain Metastases
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 24
Testing effectiveness (Phase 2)Study completedNCT01210222
What this trial is testing

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+4 more
Gynecologic Oncology Group 35
Not applicableStudy completedNCT07204028
What this trial is testing

Early Pregnancy Ultrasound Parameters Including Corpus Luteum Doppler in Prediction of First Trimester Pregnancy Outcome in Spontaneous Pregnancies.

Who this might be right for
Fetal Conditions
Cairo University 120
Load More Results